The use of the medical ozone in the immune challenge of multidrug resistant (MDR) bacteria and the role of mitochondria

Microbes Infect. 2024 Jan-Feb;26(1-2):105242. doi: 10.1016/j.micinf.2023.105242. Epub 2023 Oct 28.

Authors

Salvatore Chirumbolo¹, Luigi Valdenassi², Umberto Tirelli³, Sergio Pandolfi², Marianno Franzini⁴

Affiliations

¹ Department of Engineering for Innovation Medicine, University of Verona, Italy. Electronic address: salvatore.chirumbolo@univr.it.
² Italian Scientific Society in Oxygen Ozone Therapy (SIOOT), Bergamo, Italy.
³ Tirelli Medical Group, Pordenone, Italy.
⁴ Italian Scientific Society in Oxygen Ozone Therapy (SIOOT), Bergamo, Italy. Electronic address: info@ossigenoozono.it.

PMID: 38380603
DOI: 10.1016/j.micinf.2023.105242

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / pharmacology
Bacteria
Drug Resistance, Multiple, Bacterial*
Mitochondria*

Substances

Anti-Bacterial Agents